Sim Guan Yu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bhd are companies leading the charge in the race to supply the Covid-19 vaccine to 32.7 million Malaysians.
Both have fill and finish facilities that have been approved by the National Pharmaceutical Regulatory Authority (NPRA) and are tipped to handle the supply of vaccines that the government purchases.
The priority list for the government is the frontliners and the elderly who are most at risk. That leaves quite a number of people who would want to be inoculated and likely to seek the vaccine from the private healthcare system.
Seizing the opportunity, there are also a host of companies wanting to bring in vaccines to cater to the private sector. From property developers to engineering companies, most are looking at registering the vaccine with the NPRA and distributing it to the private sector. ....

United States , United Kingdom , United Arab Emirates , New Zealand , Saudi Arabia , Institut Jantung Negara , Datuk Hamzah Zainuddin , Zuellig Pharma , Bintai Kinden , Rosli Dahlan , Adham Baba , Sim Guan Yu , Sinopharm Covid , Zuellig Pharma Sdn Bhd , Cansino Biologics , Leong Hoy Kum , Solution Group Bhd , Hunan Changde Medical Co Ltd , China National Pharmaceutical Group , Drug Administration , Solution Group , Generex Biotechnology Corp , China National Pharmaceutical Group Corp , National Institutes Of Biotechnology Malaysia , Mah Sing Group Bhd , National Pharmaceutical Regulatory Authority ,